Word

BIOSIDUS

Status

Dead

Status Code

606

Status Date

Monday, March 4, 2019

Serial Number

87305666

Mark Type

3000

Filing Date

Wednesday, January 18, 2017

Published for Opposition

Tuesday, December 5, 2017

Abandoned Date

Monday, March 4, 2019

Trademark Owner History

Biosidus S.A. - Owner At Publication

Classifications

5 Pharmaceutical preparations for human consumption, namely, pharmaceutical preparations for the treatment of neutropenia, multiple-sclerosis, hepatitis B, hepatitis C, cancer, sarcoma of Kaposi, normalization of intestinal flora, stimulation of cellular growth and reproductions, anemia, and osteoporosis; Chemical preparations for pharmaceutical or medical purposes for human and animal disease, namely, chemical preparations for the treatment of neutropenia, multiple-sclerosis, hepatitis B, hepatitis C, cancer, sarcoma of Kaposi, normalization of intestinal flora, stimulation of cellular growth and reproductions, anemia, and osteoporosis

42 Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Laboratory research services relating to pharmaceuticals; Chemical analysis; Working on and evaluation of chemical analyses; Biological research; Biomedical research services; Biotechnology research; Chemical research; Compiling data for research purposes in the field of medical science and medical consultancy; Laboratory research in the field of biotechnology and pharmaceutical preparations for human consumption; Laboratory research services relating to pharmaceuticals

44 Consulting services in the field of health; Consulting services in the fields of diagnostic medical testing and nutrition; Counseling services in the fields of health, nutrition and lifestyle wellness; Genetic counseling; Genetic testing for medical purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical advisory services; Medical and pharmaceutical consultation; Medical assistance services; Pharmaceutical advice; Pharmaceutical compounding services

Color is not claimed as a feature of the mark.
The mark consists of the wording "BIOSIDUS" and design; the design element, which is positioned to the left of the term "BIOSIDUS", consists of an incomplete oval with a wavy line running through the oval from upper left portion to the lower right portion of the oval.
The wording "BIOSIDUS" has no meaning in a foreign language.

Trademark Events

Mar 4, 2019

Abandonment Notice E-Mailed - No Use Statement Filed

Mar 4, 2019

Abandonment - No Use Statement Filed

Aug 1, 2018

Notice Of Approval Of Extension Request E-Mailed

Jul 30, 2018

Extension 1 Granted

Jul 30, 2018

Extension 1 Filed

Jul 30, 2018

Teas Extension Received

Jan 30, 2018

Noa E-Mailed - Sou Required From Applicant

Dec 5, 2017

Official Gazette Publication Confirmation E-Mailed

Dec 5, 2017

Published For Opposition

Nov 15, 2017

Notification Of Notice Of Publication E-Mailed

Oct 24, 2017

Approved For Pub - Principal Register

Oct 24, 2017

Teas/Email Correspondence Entered

Oct 24, 2017

Correspondence Received In Law Office

Oct 24, 2017

Assigned To Lie

Oct 10, 2017

Teas Response To Office Action Received

Apr 14, 2017

Notification Of Non-Final Action E-Mailed

Apr 14, 2017

Non-Final Action E-Mailed

Apr 14, 2017

Non-Final Action Written

Apr 13, 2017

Assigned To Examiner

Jan 26, 2017

Notice Of Design Search Code E-Mailed

Jan 25, 2017

New Application Office Supplied Data Entered In Tram

Jan 21, 2017

New Application Entered In Tram